TRV-2026-1678Version 1 · Certified

Written 2026-10-17 10:41:19 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1678
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-17T10:41:19.988985Z
status: published
lens: trace
sector: health
headline: Intraoperative fluorescence spectroscopy for IDH classification in glioma: a feasibility study
dek: Background Molecular features are fundamental to both the diagnosis and prognosis of gliomas. Specific molecular features are generally unavailable at the time of index surgery; however, upfront knowledge of molecular characteristics could meaningfully inform surgical strategy. Aims/objectives To determine the feasibility of a machine learning model trained on fluorescence spectral features to classify IDH mutation and MGMT promoter methylation status in glioma tissue. Methods Tissue samples were collected durin…
gain_title: In a 27-patient pilot, a machine learning model trained on 5-ALA fluorescence spectra identified IDH-mutant glioma samples with 87% accuracy, suggesting possible real-time intraoperative molecular guidance.
problem_title: The same model could not reliably classify MGMT promoter methylation status, so the approach did not extend to this second molecular marker.
trace_subject: Machine learning classification of glioma molecular markers from intraoperative fluorescence spectra
gain_reading: In a 27-patient pilot, a machine learning model trained on 5-ALA fluorescence spectra identified IDH-mutant glioma samples with 87% accuracy, suggesting possible real-time intraoperative molecular guidance.
gain_evidence: IDH-mutant samples were identified with 87% accuracy.
problem_reading: The same model could not reliably classify MGMT promoter methylation status, so the approach did not extend to this second molecular marker.
problem_evidence: The algorithm was unable to reliably classify MGMT methylation.
quick_read: Researchers recorded fluorescence spectra from glioma tissue taken during 5-ALA-guided surgery and used the spectra to train a machine learning algorithm. The model was tested on a held-out half of the patients and distinguished IDH-mutant samples with 87% accuracy, but it did not reliably separate MGMT methylation status.

Molecular features such as IDH status normally become known only after the initial operation, so a real-time prediction could inform surgical strategy. The study is a proof of concept with a small cohort, so it remains unclear how well the method would perform in larger and more varied groups of patients.
limitation: This is a proof-of-concept study in only 27 patients, and the authors say larger cohorts and integration of 1p/19q status are still needed; MGMT methylation could not be reliably classified.
tag: Dual reading
key_points: Twenty-seven patients were recruited and more than 8000 spectra were measured from tumour tissue. | Samples were collected during 5-ALA-guided surgery and probed with a fibre probe to record fluorescence spectra. | The fluorescence data were blinded and randomised and trimmed to relevant wavelengths before analysis. | The model was trained on half of the patients for each label and tested on the other half. | The authors call for further work integrating IDH and 1p/19q status in larger cohorts.
rundown: The study addresses a gap in neurosurgery: molecular characteristics are fundamental to glioma diagnosis and prognosis, yet they are generally unavailable at the time of the index surgery. Upfront knowledge of them could meaningfully inform surgical strategy.

Tissue specimens were each linked to recorded IDH and MGMT methylation data, which were incorporated into the machine learning algorithm. Training used fluorescence data from half of the patients with each label, and testing used the other half.

The results were mixed. IDH-mutant tissue was identified with 87% accuracy, while MGMT methylation could not be reliably classified. The authors conclude the approach shows promise for real-time intraoperative IDH prediction and describe the work as a feasibility study.
sources:
- peer_reviewed | British Journal of Neurosurgery | https://doi.org/10.1080/02688697.2026.2746372 | 2026-10-09
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
8e4e32c533781dcfac3b421119e719b68512cc447163445d9d98ffe366cbbfd0
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1678 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.